Characterization of cuproptosis identified immune microenvironment and prognosis in acute myeloid leukemia

© 2023. The Author(s), under exclusive licence to Federación de Sociedades Españolas de Oncología (FESEO)..

BACKGROUND: Recent studies have reported that cuproptosis, a novel cell death pathway, strongly correlates with mitochondrial metabolism. In addition, the studies reported that cuproptosis plays a role in the development of several cancers and is regulated by protein lipoylation. During cuproptosis, copper binds to the lipoylated proteins and mediates cancer progression. However, the role of cuproptosis in acute myeloid leukemia (AML) patients is yet to be explored.

METHODS: This study curated seven cuproptosis-related-genes (CRGs): FDX1, DLAT, PDHB, PDHA1, DLD, LIAS, and LIPT1 to determine cuproptosis modification patterns and the CRGs signature in AML. The CIBERSORT and ssGSEA algorithms were utilized to evaluate the infiltration levels of different immune cell subtypes. A cuproptosis score system based on differentially expressed genes (DEGs) was constructed using the least absolute shrinkage and selection operator (LASSO) regression analysis. The developed cuproptosis score system was validated using two immunotherapy datasets, IMvigor210 and GSE78220.

RESULTS: Three distinct cuproptosis regulation patterns were identified using the Beat AML cohort. The results demonstrated that the three cuproptosis regulation patterns were correlated with various biological pathways and clinical outcomes. Tumor microenvironment (TME) characterization revealed that the identified cuproptosis regulation patterns were consistent with three immune profiles: immune-desert, immune-inflamed, and immune-excluded. The AML patients were grouped into low- and high-score groups based on the cuproptosis score system abstracted from 486 cuproptosis-related DEGs. Patients with lower cuproptosis scores were characterized by longer survival time and attenuated immune infiltration. It was found that lower cuproptosis scores were strongly correlated with lower somatic mutation frequency. Moreover, patients with lower cuproptosis scores presented more favorable immune responses and dual clinical benefits among external validation cohorts.

CONCLUSIONS: Cuproptosis phenotypes are significantly correlated with immune microenvironment complexity and variety. Cuprotopsis regulates the response of cancer cells to the immune system. Quantitatively assessing cuproptosis phenotypes in AML improves the understanding and knowledge regarding immune microenvironment characteristics and promotes the development of therapeutic interventions.

Medienart:

E-Artikel

Erscheinungsjahr:

2023

Erschienen:

2023

Enthalten in:

Zur Gesamtaufnahme - volume:25

Enthalten in:

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico - 25(2023), 8 vom: 24. Aug., Seite 2393-2407

Sprache:

Englisch

Beteiligte Personen:

Luo, Dongmei [VerfasserIn]
Liu, Songyang [VerfasserIn]
Luo, Jie [VerfasserIn]
Chen, Hong [VerfasserIn]
He, Zherou [VerfasserIn]
Gao, Zicheng [VerfasserIn]
Wen, Ziyu [VerfasserIn]
Liu, Xiaoli [VerfasserIn]
Xu, Na [VerfasserIn]

Links:

Volltext

Themen:

Acute myeloid leukemia
Chemotherapy
Cuproptosis
Immune microenvironment
Immunotherapy
Journal Article
Prognostic signature

Anmerkungen:

Date Completed 28.06.2023

Date Revised 28.06.2023

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1007/s12094-023-03118-4

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM353329134